Tetra Bio-Pharma Inc. (TBPMQ)
OTCMKTS
· Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
Apr 23, 2025, 4:00 PM EDT
Tetra Bio-Pharma Cash Flow Statement
Financials in millions CAD. Fiscal year is December - November.
Millions CAD. Fiscal year is Dec - Nov.
Fiscal Year | TTM | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | 2014 - 2016 |
---|---|---|---|---|---|---|---|
Period Ending | Aug '22 Aug 31, 2022 | Nov '21 Nov 30, 2021 | Nov '20 Nov 30, 2020 | Nov '19 Nov 30, 2019 | Nov '18 Nov 30, 2018 | Nov '17 Nov 30, 2017 | 2014 - 2016 |
Net Income | -39.02 | -52.18 | -26.48 | -15.28 | -7.57 | -6.23 | Upgrade
|
Depreciation & Amortization | 0.1 | 0.11 | 0.03 | 0.03 | - | 0.01 | Upgrade
|
Loss (Gain) From Sale of Assets | - | - | - | - | -4.23 | - | Upgrade
|
Asset Writedown & Restructuring Costs | 23.98 | 23.98 | 0.4 | - | - | - | Upgrade
|
Loss (Gain) From Sale of Investments | 1.56 | 1.24 | - | - | - | - | Upgrade
|
Loss (Gain) on Equity Investments | 0.65 | 0.95 | 0.27 | - | - | - | Upgrade
|
Stock-Based Compensation | 0.26 | 1.05 | 0.57 | 0.23 | 1.43 | 2.31 | Upgrade
|
Other Operating Activities | 0.11 | 0.11 | 5.32 | 2.2 | -0.27 | -0.19 | Upgrade
|
Change in Accounts Receivable | 0.4 | 0.4 | -0.36 | 0.47 | -0.57 | -0.13 | Upgrade
|
Change in Inventory | - | - | - | - | 0.04 | -0.04 | Upgrade
|
Change in Accounts Payable | 3.9 | -0.56 | 2.84 | -0.79 | 2.04 | 0.35 | Upgrade
|
Change in Other Net Operating Assets | -0.13 | -0.38 | -0.29 | 0.31 | -0.39 | 0.03 | Upgrade
|
Operating Cash Flow | -8.18 | -25.28 | -19.64 | -17.34 | -9.51 | -3.89 | Upgrade
|
Capital Expenditures | -0.01 | -0.34 | -0.24 | -0.25 | - | - | Upgrade
|
Cash Acquisitions | - | - | - | -3.43 | -2.48 | - | Upgrade
|
Divestitures | - | - | - | - | 0.35 | - | Upgrade
|
Sale (Purchase) of Intangibles | -0.02 | -0.82 | -1.91 | - | - | -0.75 | Upgrade
|
Investment in Securities | -0.65 | -0.97 | -1.26 | - | - | - | Upgrade
|
Investing Cash Flow | -0.68 | -2.12 | -3.42 | -3.69 | -2.13 | -0.75 | Upgrade
|
Long-Term Debt Issued | - | 3 | - | - | - | - | Upgrade
|
Total Debt Issued | - | 3 | - | - | - | - | Upgrade
|
Short-Term Debt Repaid | - | -2 | - | - | - | - | Upgrade
|
Total Debt Repaid | -1.45 | -2 | - | - | - | - | Upgrade
|
Net Debt Issued (Repaid) | -1.45 | 1 | - | - | - | - | Upgrade
|
Issuance of Common Stock | 2.63 | 31.45 | 27.04 | 8.61 | 24.63 | 5.62 | Upgrade
|
Other Financing Activities | -0.4 | -2.67 | -3.52 | 1.12 | -1.59 | -0.01 | Upgrade
|
Financing Cash Flow | 0.78 | 29.78 | 23.52 | 9.73 | 23.03 | 5.62 | Upgrade
|
Net Cash Flow | -8.09 | 2.39 | 0.46 | -11.3 | 11.39 | 0.97 | Upgrade
|
Free Cash Flow | -8.2 | -25.61 | -19.88 | -17.6 | -9.51 | -3.89 | Upgrade
|
Free Cash Flow Per Share | -0.02 | -0.06 | -0.08 | -0.09 | -0.07 | -0.04 | Upgrade
|
Levered Free Cash Flow | -3.52 | -16.79 | -11.26 | -9.2 | -4.71 | -2.44 | Upgrade
|
Unlevered Free Cash Flow | -3.21 | -15.6 | -11.26 | -9.2 | -4.71 | -2.44 | Upgrade
|
Change in Net Working Capital | -4.17 | 0.54 | -3.1 | 1.03 | -1.4 | -0.16 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.